These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9635685)

  • 1. CD44V6 expression in human colorectal carcinoma.
    Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
    Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of insulin-like growth factor-1 receptor in human colorectal cancer.
    Hakam A; Yeatman TJ; Lu L; Mora L; Marcet G; Nicosia SV; Karl RC; Coppola D
    Hum Pathol; 1999 Oct; 30(10):1128-33. PubMed ID: 10534157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
    Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
    Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
    Zhang JC; Wang ZR; Cheng YJ; Yang DZ; Shi JS; Liang AL; Liu NN; Wang XM
    World J Gastroenterol; 2003 Jul; 9(7):1482-6. PubMed ID: 12854146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CD44v6 in colon: from normal to malignant.
    Afify A; Durbin-Johnson B; Virdi A; Jess H
    Ann Diagn Pathol; 2016 Feb; 20():19-23. PubMed ID: 26621455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
    Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
    J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
    Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
    Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.
    Li JQ; Miki H; Ohmori M; Wu F; Funamoto Y
    Hum Pathol; 2001 Sep; 32(9):945-53. PubMed ID: 11567224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
    Weichert W; Knösel T; Bellach J; Dietel M; Kristiansen G
    J Clin Pathol; 2004 Nov; 57(11):1160-4. PubMed ID: 15509676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.
    Bendardaf R; Lamlum H; Ristamäki R; Pyrhönen S
    Oncol Rep; 2004 Jan; 11(1):41-5. PubMed ID: 14654900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors.
    Ogura E; Senzaki H; Yoshizawa K; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(5B):3669-75. PubMed ID: 9854475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of CD44 variants expression in colorectal cancer.
    Li XD; Ji M; Wu J; Jiang JT; Wu CP
    Tumori; 2013; 99(1):88-92. PubMed ID: 23549006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.